Results 121 to 130 of about 60,573 (236)

Tenofovir treatment in patients with lamivudine-resistant hepatitis B mutants strongly affects viral replication [PDF]

, 2002
Florian van Bömmel, Thomas Wünsche, Dirk Schürmann, Thomas Berg   +3 more
openalex   +1 more source

Immunological and virological outcomes in children on lamivudine monotherapy: A South African public sector experience

, 2022
Zinhle Makatini, J T Blackard, O E Towobola, P Miles, Siyazi Mda, S Mda   +5 more
openalex   +2 more sources

Immunovirological treatment out- comes after 2 years of antiretroviral therapy in children living with the human immune deficiency virus in Lagos Nigeria

Nigerian Journal of Paediatrics
Background/objective: The World Health Organization (WHO) recommends routine assessment of antiretroviral treatment outcomes to detect treatment failure early and prevent the development of drug resistance. The aim of this study was to describe treatment
Nwaiwu O, Akindele AJ, Akanmu AS, Adeyemi OO   +3 more
doaj  

Evaluation of cardiovascular biomarkers in a randomized trial of fosamprenavir/ritonavir vs. efavirenz with abacavir/lamivudine in underrepresented, antiretroviral-naïve, HIV-infected patients (SUPPORT): 96-week results [PDF]

, 2013
Princy Kumar, Edwin DeJesus, Gregory Huhn, Louis Sloan, Catherine B. Small, Howard Edelstein, Franco Felizarta, Ritche Hao, Lisa Ross, Britt Stancil, Keith A. Pappa, Belinda Ha, Belinda Ha   +12 more
openalex   +1 more source

Referee report. For: AntiRetroviral Therapy In Second-line: investigating Tenofovir-lamivudine-dolutegravir (ARTIST): protocol for a randomised controlled trial [version 1; peer review: 2 approved, 1 approved with reservations]

, 2022
Loice Achieng Ombajo
openalex   +1 more source

A Proof‐of‐Concept Study of Short‐Cycle Intermittent Antiretroviral Therapy with a Once‐Daily Regimen of Didanosine, Lamivudine, and Efavirenz for the Treatment of Chronic HIV Infection [PDF]

, 2004
Mark Dybul, Elizabeth Nies‐Kraske, Robin Dewar, Frank Maldarelli, Claire W. Hallahan, Marybeth Daucher, Stephen C. Piscitelli, Linda A. Ehler, Ann Weigand, Sarah Palmer, Julia A. Metcalf, Richard T. Davey, Diane M. Rock Kress, April Powers, Ingrid A. Beck, Lisa M. Frenkel, Michael Baseler, John M. Coffin, Anthony S. Fauci   +18 more
openalex   +1 more source

Prevention by Lamivudine of Hepatocellular Carcinoma in Patients Infected with Hepatitis B Virus

Gut and Liver, 2007
Background/Aims: This study evaluated the prevention by lamivudine of hepatocellular carcinoma (HCC) in chronic hepatitis B patients. Methods: Lamivudine therapy was administered to 879 of the 2,511 patients who satisfied our analysis inclusion criteria.
doaj   +1 more source

Differential Extracellular and Intracellular Concentrations of Zidovudine and Lamivudine in Semen and Plasma of HIV-1-Infected Men

, 2008
Julie B. Dumond, Y. Sunila Reddy, Luigi Troiani, José F. Rodrígúez, Arlene S. Bridges, Susan A. Fiscus, Geoffrey J. Yuen, Myron S. Cohen, Angela D. M. Kashuba   +8 more
openalex   +1 more source

Neurological efficacy of stavudine, zidovudine, and lamivudine [PDF]

, 1998
Magnus Gisslén, Dietmar Fuchs, Lars Hagberg   +2 more
openalex   +1 more source

Comparison Between Entecavir and Lamivudine as Hepatitis B Reactivation Prophylaxis in Cancer Patient with Chemotherapy [PDF]

, 2015
Aim: to compare between entecavir and lamivudine as hepatitis B reactivation prophylaxis in cancer patient with chemotherapyMethod: a literature searching in PubMed was done. At the beginning, 8 articles were found. Chosen article in this EBCR were those
Dharaniyadewi, D. (Dana), Hamonangan, R. (Rachmat), Siregar, N. N. (Nia)   +2 more
core